MedPath

Effect of Anthocyanins Extracted From Purple Potatoes on Healthy Study Subjects' Postprandial Glycemia and Insulinemia

Not Applicable
Completed
Conditions
Postprandial Glycemia
Interventions
Other: Dietary
Registration Number
NCT02940080
Lead Sponsor
University of Turku
Brief Summary

A randomized, single-blind cross-over clinical nutrition trial will be conducted. The effects of yellow-fleshed potatoes and yellow-fleshed potatoes supplemented with anthocyanins extracted from purple-fleshed potatoes on healthy men's postprandial glycemia and insulinemia will be compared. Additionally, the postprandial metabolism and metabolites, and the appearance and metabolism of the flavonoids and their metabolites is studied in plasma, urine and feces.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
18
Inclusion Criteria
  • Age 18-45
  • Male
  • No regular medication
  • No participation in a drug trial or blood donation within 2 months
  • Non-smoker
  • Signs informed consent
  • Body mass index 18.5-27 kg/m2
  • Fasting plasma cholesterol < 5.5 mmol/l
  • Fasting plasma triacylglycerols < 2.6 mmol/l
  • Fasting plasma glucose 4-6 mmol/l
  • blood pressure <140/80 mmHg
  • hemoglobin>130 g/l
  • Fasting plasma alanine amino transferase (ALAT) <60 U/l (normal liver function)
  • Fasting plasma thyroid-stimulating hormone (TSH) 0.4 - 4.5 mU/l (normal thyroid function)
  • Fasting plasma creatinine <118 µmol/l (normal kidney function)
Exclusion Criteria
  • Regular smoking
  • Alcohol abuse
  • Regular medication

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Yellow potatoDietary350 g of steam-cooked mashed potatoes in water
Anthocyanins and yellow potatoDietary168 mg of anthocyanins extracted from purple-fleshed potatoes added to 350 g of steam-cooked mashed potatoes in water
Primary Outcome Measures
NameTimeMethod
Plasma insulin concentration0min, 20min, 40min, 60min, 90min, 120min, 180min, 240min
Plasma glucose concentration0min, 20min, 40min, 60min, 90min, 120min, 180min, 240min
Secondary Outcome Measures
NameTimeMethod
Concentrations and quality of metabolites and flavonoid color compounds and their metabolites in plasma (NMR and (U)HPLC-MS/MS measurements)0min, 20min, 40min, 60min, 90min, 120min, 180min, 240min
Concentrations and quality of metabolites and flavonoid color compounds and their metabolites in urine (NMR and (U)HPLC-MS/MS measurements)Before meal, and 0-4h, 4-8h, 8-16h, 16-24 h
Concentrations and quality of metabolites and flavonoid color compounds and their metabolites in feces (NMR and (U)HPLC-MS/MS measurements)before and after meal
Area under the glucose concentration curve (AUC)0min, 20min, 40min, 60min, 90min, 120min, 180min, 240min
Area under the insulin concentration curve (AUC)0min, 20min, 40min, 60min, 90min, 120min, 180min, 240min

Trial Locations

Locations (1)

Department of Biochemistry, University of Turku

🇫🇮

Turku, Finland

© Copyright 2025. All Rights Reserved by MedPath